Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels

US8338395B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Doris Hubler · Jena, DE
• Sabine Fricke · Jena, DE
• Jan-Peter Ingwersen · Berlin, DE
• Wilheim Kuhnz · Berlin, DE

Key dates

• Filing date: Feb 24, 2009
• Grant date: Dec 25, 2012
• Expiry date: Feb 11, 2031

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Described are methods for providing prolonged physiologically acceptable steady state serum testosterone levels in a patient deficient in endogenous testosterone levels, methods for male contraception and methods for treating a disease or symptom associated with deficient endogenous levels of testosterone in a man, by intramuscularly administering testosterone esters in a vehicle.